To Westminster, where last week Kim Leadbeater’s Assisted Dying bill began the evidence session of committee stage. But rather than provide much needed clarification about the scope of suicide bill, the three days of evidence sessions instead threw up even more questions about the safety of the legislation. After paying careful attention to the hours
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in